Novavax
NVAX
#5358
Rank
A$2.12 B
Marketcap
A$12.94
Share price
15.41%
Change (1 day)
34.24%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): A$0.75 Billion

According to Novavax's latest financial reports the company's current earnings are A$1.08 Billion. , an increase over its 2024 earnings that were of -A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 A$0.64 B-396.87%
2024 -A$0.22 Billion-70.39%
2023 -A$0.74 Billion-16.59%
2022 -A$0.88 Billion-62.58%
2021 -A$2.35 Billion320.54%
2020 -A$0.56 Billion234.22%
2019 -A$0.17 Billion-30.17%
2018 -A$0.24 Billion1.69%
2017 -A$0.24 Billion-36.44%
2016 -A$0.37 Billion70.4%
2015 -A$0.22 Billion89.27%
2014 -A$0.12 Billion59.83%
2013 -A$71.59 Million81.9%
2012 -A$39.36 Million50.33%
2011 -A$26.18 Million
2009 -A$51.67 Million8.8%
2008 -A$47.49 Million18.01%
2007 -A$40.24 Million18.33%
2006 -A$34.01 Million168.31%
2005 -A$12.68 Million-62.51%
2004 -A$33.81 Million52.4%
2003 -A$22.19 Million-28.21%
2002 -A$30.91 Million
2000 -A$17.61 Million177%
1999 -A$6.36 Million-11.54%
1998 -A$7.19 Million10.64%
1997 -A$6.5 Million-9.62%
1996 -A$7.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.59 B 3,418.72%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.08 B 2,093.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.49 B 2,935.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$13.67 B 2,029.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-A$0.98 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.4 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$28.55 M-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.23 Million-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.36 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.22 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA